CW July 2005
Volume 14Issue Number 7 July 2005 ISSN 10593802 Combining Irinotecan With FOLFIRI Reduces Advanced Colon Cancer RecurrenceThe addition of irinotecan to infused 5-FU/Leucovorin (FOLFIRI) significantly reduces the risk of colon cancer recurrence among stage III patients, and is a valid treatment option for these advanced stage patients, according to a new study.
Go to Previous Page Go to Next Page Source and Additional Reading E. Van Cutsem, 41st Annual Meeting of the American Society of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
